Basic Femara Information

• INN (International Nonproprietary Name): Letrozole
• Brand Names Available In Canada (English): Femara
• ATC Code: L02BG04 — Aromatase Inhibitors: Antineoplastic And Immunomodulating Agents, Hormone Antagonists And Related Agents, Aromatase Inhibitors.
• Forms & Dosages: Oral Film-Coated Tablets, 2.5 Mg; Typical Packaging Includes Blisters Or Bottles (7, 10, 14, 28, 30, Or 100 Tablets).
• Local Manufacturers And World-Based Suppliers: Novartis Pharma AG (Originator) And Licensed Generics From Suppliers Such As Cipla, Sun Pharma, Hetero, Sandoz, Alphapharm.
• Regulatory Registration & Approval Status: Health Canada Approved; Also Approved By EMA, FDA, TGA, And Listed In Multiple Jurisdictions.
• Classification: Prescription Only (Rx) — Letrozole/Femara Is Never OTC.
• Standard Dosages Per Condition: Adjuvant, Advanced/Metastatic, And Extended Adjuvant Use — 2.5 Mg Once Daily.
• Dosage Adjustments: Not Indicated For Children; No Routine Adjustment For Elderly; Caution In Severe Hepatic Impairment And In Severe Renal Dysfunction (CrCl <10 Ml/Min).
• Treatment Durations And Regimens: Adjuvant/Extended Adjuvant Commonly 5 Years; May Contribute To A Total Of Up To 10 Years When Sequenced With Tamoxifen; Metastatic Therapy Continued Until Progression Or Unacceptable Toxicity.
• Missed Dose & Overdose Guidance: Take Missed Dose When Remembered Unless Close To Next Dose; Never Double Dose; Overdose Is Treated Supportively.
• Storage & Transport: Store Below 30°C; Protect From Moisture And Heat; Keep In Original Blister.
• Absolute Contraindications: Pre-Menopausal Women, Pregnancy, Lactation, Known Hypersensitivity To Letrozole Or Excipients.
• Relative Contraindications: Severe Hepatic Impairment, Severe Renal Dysfunction, Pre-Existing Osteoporosis, Ischemic Heart Disease, Concurrent Potent CYP450 Modulators.
• Common Side Effects: Hot Flushes, Musculoskeletal Pain/Arthralgia, Fatigue, Nausea, Headache, Mild Bone Density Loss, Hypercholesterolemia.

Latest Research Highlights

Worried about whether Femara really improves outcomes compared with older endocrine options?

Recent Canadian and international evidence (2022–mid‑2025) reinforces letrozole's role in postmenopausal, hormone receptor–positive breast cancer for adjuvant and extended adjuvant therapy.

Meta-analyses and cohort studies report improved disease‑free survival when switching from tamoxifen to an aromatase inhibitor or when extending endocrine therapy to five years total with letrozole.

Canadian cohorts emphasise real‑world safety signals such as measurable declines in bone mineral density and modest rises in LDL cholesterol, driving integrated bone‑health pathways in oncology clinics.

Immuno‑oncology combinations involving aromatase inhibitors remain investigational and are not standard of care.

• Clinical Endpoints Summarized: disease‑free survival, overall survival, bone mineral density change, fracture incidence, lipid profile shifts, quality of life, and adherence.
• Patient-Centred Notes: Canadian studies often prioritise quality‑of‑life endpoints and report adherence barriers such as polypharmacy and travel to urban centres for follow‑up.

Data Highlight: Absolute benefit versus harm (example metrics) are not specified in the provided data and should be reviewed in individual trial reports or meta-analyses.

Clinical Effectiveness In Canada

Wondering how Femara performs in routine Canadian practice?

Health Canada has approved letrozole for postmenopausal women with hormone receptor–positive breast cancer, available as Femara 2.5 Mg tablets through community and hospital pharmacies.

Effectiveness evidence in Canadian practice aligns with EMA and FDA findings that daily 2.5 Mg improves disease‑free survival in early and advanced settings.

Practical Canadian considerations include checking the Drug Identification Number (DIN) on dispensed products to confirm brand or generic substitution.

Provincial formulary listings influence access and may require specialist prescribing or prior authorization for adjuvant and metastatic indications.

• Monitoring Checklist: baseline DEXA (bone mineral density), fasting lipid profile (including LDL), calcium and vitamin D status, and cardiovascular risk assessment.

Patient Centre Note: Pharmacists should provide bilingual counselling and bilingual labelling expectations are standard in Canada.

Indications And Expanded Uses

Are you unsure whether letrozole is approved for your situation or if it’s ever used outside oncology?

Approved indications in Canada and internationally focus on postmenopausal women with hormone receptor‑positive early or advanced breast cancer for adjuvant therapy, first‑line metastatic therapy, and extended adjuvant use commonly up to five years.

Off‑label uses exist, most notably ovulation induction in infertility, but this is not Health Canada‑approved and requires specialist oversight due to teratogenic risk.

Approved Indication

Postmenopausal hormone receptor–positive breast cancer for adjuvant, extended adjuvant, and metastatic therapy.

Extended Adjuvant

Typically up to five years of letrozole; sequences with tamoxifen can total up to 10 years depending on specialist guidance.

Off‑Label/Infertility

Occasional use for ovulation induction outside of approved indications is not registered in most countries and requires strict specialist supervision.

• Approved Uses: adjuvant therapy, extended adjuvant therapy (Femara 2.5 Mg), and first‑line metastatic therapy.
• Off‑Label Uses: infertility/ovulation induction — not Health Canada‑approved; specialist oversight required.

Practical Note: Premenopausal women are contraindicated unless rendered postmenopausal with ovarian suppression under specialist care, and contraception counselling is mandatory for women of childbearing potential.

Composition And Brand Landscape

Curious what is actually inside the tablet and how brands differ?

Active ingredient: letrozole (INN) in 2.5 Mg oral film‑coated tablets; the principal brand in Canada is Femara, with generics widely available internationally.

Packaging and suppliers vary by country; Femara is the standard pharmacy product in Canada and is commonly dispensed in blister packs or standard retail packaging.

• Substitution Checklist For Pharmacists: confirm DIN, confirm manufacturer, check expiry date, counsel on pill appearance when switching between Femara and letrozole generic products.

Patient Tip: Ask the pharmacist for bilingual product monographs and confirm pill appearance to reduce confusion if the product changes across refills.

Contraindications And Special Precautions

Should you be concerned about who must not take letrozole or who needs special monitoring?

Absolute contraindications are pre‑menopausal status, pregnancy, lactation, and known hypersensitivity to letrozole or excipients.

Relative contraindications that require enhanced monitoring include severe hepatic impairment, severe renal dysfunction (CrCl <10 Ml/Min), pre‑existing osteoporosis, and ischemic heart disease.

Concurrent potent CYP450 inducers or inhibitors also warrant medication review before starting.

Absolute

Pre‑menopausal Women; Pregnancy; Lactation; Hypersensitivity To Letrozole Or Excipients.

Relative

Severe Hepatic Impairment; Severe Renal Dysfunction; Significant Osteoporosis; Ischemic Heart Disease; Concurrent Potent CYP450 Modulators.

Canadian High‑Risk Populations Include Older Adults With Multimorbidity, Indigenous And Remote Community Patients With Limited DEXA Access, And Patients On Multiple Cardiovascular Medications.

• Practical Steps: perform baseline DEXA, a fracture risk assessment, lipid panel, and a full medication reconciliation; document all findings in the chart and notify the provincial cancer care program.

Data Highlight: Teratogenic risk is significant; pregnancy must be excluded before starting and effective contraception should be used during therapy.

Dosage Guidelines

How should Femara be taken and what happens if a dose is missed?

The standard adult dosing is 2.5 Mg once daily, oral, with or without food, and the tablet is the only authorised form.

Typical regimens are five years for adjuvant/extended adjuvant use and continued until progression or intolerance for metastatic disease.

• Missed Dose Advice: take as soon as remembered unless the next dose is near; never double the dose.
• Overdose Advice: no specific antidote; provide supportive care and monitoring.

Pharmacist Checklist: confirm dosing adherence at each refill and flag long‑term users for periodic bone health follow‑up and lipid monitoring.

Interactions Overview

What medicines or supplements could affect how letrozole works?

Letrozole has a modest interaction profile but requires attention to drugs that affect CYP450 enzymes and agents that impact bone or lipid metabolism.

Potent CYP450 inducers such as rifampin and some anticonvulsants may reduce letrozole exposure, while strong inhibitors could increase levels; review all prescriptions, over‑the‑counter medicines, and supplements.

Common interactions in Canada include statins and bisphosphonates where co‑management is frequently needed rather than absolute contraindication.

• Pharmacist Action: perform medication reconciliation, flag CYP450 modulators such as St. John’s wort, and counsel patients on supplements that may interact.

Data Highlight: Letrozole is a prescription‑only medicine and should not be treated as an over‑the‑counter option.

Cultural Perceptions And Patient Habits

What do patients say about taking Femara and how does culture affect treatment?

Canadian patients often view oncology drugs as part of publicly funded care, and expectations about access and out‑of‑pocket costs strongly shape adherence.

Rural and Indigenous communities report travel burdens for oncology follow‑up and DEXA scans, which increases reliance on local pharmacists for counselling and coordination of care.

• Common Patient Concerns: side effects such as hot flushes and joint pain, drug costs, travel logistics, and pill confusion when switching brands.
• Suggested Pharmacist Responses: provide clear side‑effect management tips, check provincial coverage, coordinate local labs or telehealth, and offer bilingual materials.

Cultural Competence Tips: involve family decision‑makers when appropriate, coordinate with Indigenous health liaison services, and always offer English and French written materials where needed.

Availability And Pricing Patterns

Where can Femara be purchased in Canada and what will it cost?

Femara (letrozole 2.5 Mg) is prescription‑only and routinely stocked in Canadian pharmacy chains and hospital pharmacies.

Provincial formularies may fully cover letrozole for eligible patients, while private insurance or out‑of‑pocket costs vary depending on brand, generic dispensing, and pharmacy markups.

• Steps To Verify Coverage: check DIN, confirm provincial plan eligibility (Ontario Drug Benefit, BC PharmaCare, RAMQ), and ask the pharmacist to check prior authorization requirements.
• Cost Mitigation: consider generic letrozole options and discuss special access or compassionate supply routes with the oncology team where appropriate.

Purchasing Note: In accordance with regulatory classification, Femara is available by prescription only; pharmacists should confirm coverage and provide a cost estimate at point of care.

Comparable Medicines And Preferences

How does Femara compare with other aromatase inhibitors or tamoxifen?

Main comparators in Canada are anastrozole and exemestane, with tamoxifen used in premenopausal or different clinical contexts.

Choice among aromatase inhibitors depends on tumour biology, bone health, lipid profile, tolerability, and previous endocrine therapy.

• Pros/Cons Checklist: Letrozole — robust disease‑free survival data but more pronounced bone density impact; Anastrozole — similar efficacy with a slightly different side‑effect profile; Exemestane — steroidal option useful after intolerance to non‑steroidal AIs.

Pharmacists Should Confirm Substitution Rules When Switching Between Femara And Letrozole Generic Products And Counsel Patients About Changes In Pill Appearance And Potential Differences In Packaging.

FAQ

Can I take letrozole if I’m still menstruating?

No — letrozole is contraindicated in pre‑menopausal women unless ovarian suppression is in place and management is by a specialist.

Will provincial drug plans pay for Femara?

Many provinces list letrozole for eligible cancer indications; pharmacists can check DIN and coverage under Ontario Drug Benefit, BC PharmaCare, or RAMQ at the point of care.

What about bone health while taking letrozole?

Baseline DEXA and regular monitoring are recommended, along with calcium, vitamin D, lifestyle measures, and bisphosphonates when indicated.

Can I switch between brand and generic?

Yes — pharmacies may substitute by DIN; expect counselling about pill appearance when Femara is replaced by a letrozole generic such as Sandoz Letrozole or Teva‑Letrozole.

Is letrozole safe to take with my cholesterol meds?

Often yes, but check for interactions with specific statins and monitor lipids according to the monitoring checklist.

• Quick Action Items: call your oncologist for pregnancy concerns; ask your pharmacist to check the DIN and provincial coverage; schedule baseline DEXA before starting.

Guidelines For Proper Use

What should pharmacists and clinicians do to ensure proper use of Femara?

• Verify Indication And DIN On The Prescription.
• Document Baseline DEXA, Lipid Profile, And Fracture Risk.
• Provide Bilingual Counselling And Written Materials Where Appropriate.
• Coordinate With Provincial Cancer Care Programs For Coverage And Follow‑Up.
• Check Drug Interactions And Perform Medication Reconciliation.
• Schedule DEXA Reminders For Long‑Term Users.

For rural or remote patients, arrange telehealth oncology reviews and local DEXA referrals where possible, and engage Indigenous health services for culturally appropriate care.

Final Note: Letrozole is prescription only — always check the Health Canada monograph and provincial formulary links for current requirements.

Delivery Across Canada (English)

Purchase Context

Femara is dispensed by prescription in Canada and pharmacists will confirm coverage and DIN before supply.

Online Canadian pharmacies commonly offer home delivery and can help verify provincial coverage and generic options during the ordering process.

Please consult your oncologist or pharmacist for individual advice about letrozole 2.5 Mg (Femara) and for help navigating provincial plans such as Ontario Drug Benefit, BC PharmaCare, or RAMQ.